Search - tctmd.com

Displaying 301 - 320 of 901

Sort: Relevancy | Date

Presentation TCT 2017

Case #2: TAVR ViV With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Anupama Shivaraju

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Conference News PCR London Valves 2017

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Shelley Wood

September 28, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Daily News

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Yael L. Maxwell

August 24, 2017

Manuscript

Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort

August 08, 2017

News Daily News

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Michael O'Riordan

July 17, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Transcatheter Mitral Valve in MAC Using the Sapien 3 Device

Presenter: Robert M. Kipperman, Scott Lim, Michael Morse, MD

June 16, 2017

Presentation TVT 2017

Implantation of an Edwards Sapien 3 Valve in a Degenerated Mitral Prosthesis via the Antegrade, Trans-septal Route in a Patient With a Left Ventricular Assist Device

Presenter: Robert M. Kipperman, Scott Lim, Matthew Sherwood, MD

June 16, 2017

Presentation TVT 2017

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

Presenter: Shigeru Saito, Jonathon M. White, Mike Saji, MD

June 16, 2017

Presentation TVT 2017

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Presenter: David W.M. Muller, Lars Sondergaard, Peter den Heijer, MD

June 16, 2017

Advertisement

Case #2: TAVR ViV With SAPIEN 3 (With Discussion)

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Transcatheter Mitral Valve in MAC Using the Sapien 3 Device

Implantation of an Edwards Sapien 3 Valve in a Degenerated Mitral Prosthesis via the Antegrade, Trans-septal Route in a Patient With a Left Ventricular Assist Device

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

Severe PVL, Caused by Ventricular Migration of Evolut R, Successfully Treated With Sapien-3 Valve-in-Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content